Pavel V. Gavrilov

Dr. Pavel V. Gavrilov

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2022 in The European Physical Journal Special Topics
Verified
Journal Article
Closed access
PDF file
AVAnastasia S. Vanina
Anastasia S. Vanina
ASAlexander Sychev
Alexander Sychev
ALAnastasia Lavrova
Anastasia Lavrova
PGPavel V. Gavrilov
Pavel V. Gavrilov
PAPolina L. Andropova
Polina L. Andropova
Eugene B PostnikovEugene B Postnikov
Eugene B Postnikov

12 August 2020 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
VRV. V. Rassokhin
V. V. Rassokhin
ASA. V. Samarina
A. V. Samarina
NBN. A. Belyakov
N. A. Belyakov
TTT. N. Trofimova
T. N. Trofimova
OLO. V. Lukina
O. V. Lukina
OGO. A. Grinenko
O. A. Grinenko
The analysis of the epidemic process associated with COVID-19 is carried out, possible scenarios of the development of events are presented. The most common anamnestic data, symptoms of infection, clinical picture and possible complications are described in detail. The features of the COVID-19 course in risk groups and the algorithms of administrative and medical actions that should underlie the provision of medical care to patients with cardiovascular, oncological, rheumatological diseases, pregnant women, etc. The section of diagnostics and examination features is of particular importance, since it includes not only the definition of the causative agent of the disease, but also the main indicators that determine the severity of the clinical picture, prognosis, the nature and extent of medical care. Considerable experience is presented in the clinical practice of computed tomography of the lungs, the method, the primary and early method for identifying not only lung lesions, but also the underlying disease — COVID-19. Information is presented from literary sources based on the experience of overcoming this formidable disease and its consequences by our colleagues, as well as the experience of domestic clinicians and scientists.

26 December 2022 in Pediatrician (St. Petersburg)
Verified
Journal Article
Closed access
PDF file
GKGrigorii G. Kudriashov
Grigorii G. Kudriashov
ANAndrey O. Nefedov
Andrey O. Nefedov
GTGrigorii V. Tochilnikov
Grigorii V. Tochilnikov
SZS Zmitrichenko
S Zmitrichenko
IKIuliia Krylova
Iuliia Krylova
ЯКЯблонский Петр Казимирович
Яблонский Петр Казимирович
BACKGROUND: The potential relationship between pulmonary tuberculosis and lung cancer has been the subject of intense interest over the past few decades. Nevertheless, the features of the pathogenesis of concomitant pathology remain poorly studied. AIM: The ain of the study to develop an experimental model of the concomitant pathology of tuberculosis and lung cancer. MATERIALS AND METHODS: The study was performed on mice of the C57BL/6 line at the age of two months in four groups: 1st intact mice (n = 12), 2nd mice without a tumor infected with tuberculosis (n = 24), 3rd tumor-bearing mice not infected with tuberculosis (n = 23), 4th tumor-bearing mice infected with tuberculosis (n = 24). Individual and group parameters were evaluated using the SPSS Statistica v23 software package. RESULTS: Tumor was developed at the site of primary transplantation in all mice from groups 3 and 4, which was confirmed by visual assessment and the results of histological examination. Tumor growth in the main group was significantly less than in the control group of the tumor, which may be due to intoxication against the background of tuberculosis infection. All infected mice from groups 2 and 4 developed pulmonary tuberculosis, confirmed by computed tomography of the lungs, bacteriological and histological examination of lung samples. Mycobacterial load in the lungs was the highest in animals with concomitant pathology of tuberculosis and tumor. The survival rate of mice was determined to a large extent by tumor growth rather than by the progression of tuberculosis infection. CONCLUSIONS: The results of the study indicate the possibility of creating an experimental biological model of the concomitant pathology of tuberculosis and lung cancer in mice. The features of the course of the concomitant pathology were revealed: Lewis lung epidermoid carcinoma develops more slowly in tuberculosis infected animals than in the tumor control group; the development of the tuberculosis process in mice with a tumor occurs more intensively than in the tuberculosis infection control group. The survival rate of mice with concomitant pathology is determined more by the intensity of tumor growth than by the progression of tuberculosis.

1 January 2018 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
DEDilyara S. Esmedlyaeva
Dilyara S. Esmedlyaeva
SPSaint-Petersburg State Research Institute of Phthisiopulmonology
Saint-Petersburg State Research Institute of Phthisiopulmonology
NАN. P. Аlekseevа
N. P. Аlekseevа
PGPavel V. Gavrilov
Pavel V. Gavrilov
MPM. V. Pаvlovа
M. V. Pаvlovа
SUSt. Petersburg University
St. Petersburg University
Прогностическая роль показателей системы матриксные металлопротеиназы/ингибиторы в оценке характера репаративных изменений легочной ткани при инфильтративном туберкулезе легких

25 July 2019 in QJM: An International Journal of Medicine
Verified
Journal Article
Closed access
DCD Cheremisin
D Cheremisin
PAP Andropova
P Andropova
PGPavel V. Gavrilov
Pavel V. Gavrilov

15 August 2020 in Diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
PGPavel V. Gavrilov
Pavel V. Gavrilov
OLO. V. Lukina
O. V. Lukina
УСУ. А. Смольникова
У. А. Смольникова
SKS. V. Korobejnikov
S. V. Korobejnikov
РЕНТГЕНОЛОГИЧЕСКАЯ СЕМИОТИКА ИЗМЕНЕНИЙ В ЛЕГКИХ, СВЯЗАННЫХ С НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИЕЙ (COVID19)